COMPASS Pathways plc (CMPS) shareholders
Close on Nov 16, 2026Market cap $1.15BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Roderick Wong Joint filing with RTW Investments, LP (9.90%) | 12,971,571 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| David Kroin Joint filing with Deep Track Capital, LP (9.99%), Deep Track Biotechnology Master Fund, Ltd. (9.99%) | 9,274,589 | 9.99% | 13G (passive) | Jan 10, 2025 |
| BIT Capital GmbH | 8,148,280 | 5.90% | 13G (passive) | Sep 30, 2026 |
| RTW Investments, LP Joint filing with Roderick Wong, M.D. (8.30%) | 7,877,349 | 8.30% | 13G (passive) | Mar 31, 2025 |
| ATAI Life Sciences AG Joint filing with ATAI Life Sciences N.V. (7.50%) | 6,905,774 | 7.50% | 13D (active) amendment | Mar 5, 2025 |
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (6.60%) | 6,348,988 | 6.60% | 13G (passive) amendment | Mar 31, 2025 |
| Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (6.23%), Daniel Mack (6.23%) | 5,934,315 | 6.23% | 13G (passive) | Jun 30, 2025 |
| ATAI Life Sciences N.V. | 5,785,774 | 6.00% | 13D (active) amendment | Oct 27, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CMPS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 12,161,496 | 8.78% | $172.09M | – | 2.50% |
| Rtw Investments, LP | 10,700,974 | 7.73% | $151.42M | +68,584 | 1.29% |
| BIT Capital GmbH | 6,348,797 | 4.58% | $89.84M | +2,857,563 | 2.66% |
| Tang Capital Management LLC | 5,000,000 | 3.61% | $70.75M | +997,800 | 3.21% |
| Two Sigma Investments, LP | 4,470,485 | 3.23% | $63.26M | +1,886,986 | 0.05% |
| Marshall Wace, Llp | 4,328,682 | 3.13% | $61.25M | +290,347 | 0.05% |
| ARK Investment Management LLC | 3,451,965 | 2.49% | $48.85M | +150,915 | 0.32% |
| Point72 Asset Management, L.P. | 2,620,878 | 1.89% | $37.09M | New | 0.04% |
| Logos Global Management LP | 2,250,000 | 1.62% | $31.84M | New | 1.37% |
| Eagle Health Investments LP | 2,060,427 | 1.49% | $29.16M | – | 4.83% |
| Bank Of America Corp /De/ | 2,019,348 | 1.46% | $28.57M | +1,987,016 | 0.00% |
| DAFNA Capital Management LLC | 2,011,952 | 1.45% | $28.47M | −406,930 | 5.43% |
| NEXTBio Capital Management LP | 1,775,759 | 1.28% | $25.13M | −245,648 | 11.56% |
| Kalehua Capital Management LLC | 1,639,384 | 1.18% | $23.20M | – | 7.40% |
| UBS Group AG | 1,482,470 | 1.07% | $20.98M | −372,600 | 0.00% |
| Aisling Capital Management LP | 1,432,336 | 1.03% | $20.27M | – | 4.30% |
| Renaissance Technologies LLC | 1,431,889 | 1.03% | $20.26M | +566,535 | 0.03% |
| Candriam S.C.A. | 1,274,278 | 0.92% | $18.01M | New | 0.08% |
| Woodline Partners LP | 1,086,004 | 0.78% | $15.37M | +910,565 | 0.05% |
| Citadel Advisors LLC | 1,004,880 | 0.73% | $14.22M | +735,391 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 223 | 91M | 66.0% | 63 / 73 | 48 / 29 | 24M | 26M |
| Q1 2026 | 193 | 93M | 67.4% | 53 / 71 | 26 / 25 | 48M | 10M |
| Q4 2025 | 168 | 55M | 39.7% | 37 / 37 | 40 / 25 | 12M | 12M |
| Q3 2025 | 157 | 55M | 40.1% | 38 / 49 | 24 / 19 | 17M | 13M |
| Q2 2025 | 140 | 52M | 37.5% | 25 / 35 | 39 / 19 | 13M | 13M |
| Q1 2025 | 135 | 52M | 37.5% | 23 / 39 | 27 / 19 | 26M | 5M |
| Q4 2024 | 132 | 31M | 22.3% | 32 / 28 | 27 / 30 | 10M | 11M |
| Q3 2024 | 130 | 33M | 23.7% | 24 / 27 | 29 / 15 | 8M | 5M |
| Q2 2024 | 122 | 30M | 21.4% | 22 / 30 | 20 / 14 | 5M | 3M |
| Q1 2024 | 116 | 28M | 19.9% | 19 / 26 | 26 / 26 | 8M | 3M |
| Q4 2023 | 126 | 23M | 16.6% | 34 / 21 | 30 / 21 | 4M | 3M |
| Q3 2023 | 113 | 22M | 16.1% | 30 / 21 | 18 / 12 | 15M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
15 funds held CMPS in Q2 2026, 86% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CMPS | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | 4,463,875 | 3.22% | $50.66M | 3.25% | Jul 31, 2026 |
| iShares Biotechnology ETF | 764,943 | 0.55% | $10.82M | 0.12% | Jun 30, 2026 |
| AdvisorShares Psychedelics ETF | 359,647 | 0.26% | $5.09M | 11.45% | Jun 30, 2026 |
| Royce Smaller-Companies Growth Fund | 178,000 | 0.13% | $2.52M | 1.06% | Jun 30, 2026 |
| Simplify Propel Opportunities ETF | 114,281 | 0.08% | $1.62M | 2.09% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 81,279 | 0.06% | $1.15M | 0.13% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 62,962 | 0.05% | $822.28K | 0.00% | May 31, 2026 |
| Dunham Small Cap Growth Fund | 62,514 | 0.05% | $709.53K | 0.89% | Jul 31, 2026 |
| AdvisorShares Dorsey Wright ADR ETF | 61,700 | 0.04% | $873.06K | 2.09% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 60,753 | 0.04% | $859.65K | 0.02% | Jun 30, 2026 |
| ROBO Global Healthcare Technology and Innovation ETF | 56,358 | 0.04% | $639.66K | 0.93% | Jul 31, 2026 |
| Tiff Multi-Asset Fund | 30,931 | 0.02% | $437.67K | 0.03% | Jun 30, 2026 |
| Old Westbury Small & Mid Cap Strategies Fund | 30,489 | 0.02% | $346.05K | 0.00% | Jul 31, 2026 |
| Virtus Biotech Clinical Trials Etf | 25,731 | 0.02% | $292.05K | 0.63% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 21,455 | 0.02% | $280.20K | 0.03% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kabir Nath | Chief Executive Officer, Director | 361,028 | 0.26% | Aug 5, 2026 |
| Guy Goodwin | Chief Medical Officer | 8,000 | 0.01% | Mar 27, 2026 |
| Teri Loxam | Chief Financial Officer | 152,002 | 0.11% | Mar 27, 2026 |
| Jeffrey M. Jonas | Director | – | – | May 29, 2026 |
| Wayne Joseph Riley | Director | – | – | May 29, 2026 |
| Daphne Karydas | Director | – | – | May 29, 2026 |
| Kathleen Tregoning | Director | – | – | May 29, 2026 |
| Gino Santini | Director | – | – | May 29, 2026 |
| David Y. Norton | Director | 20,356 | 0.01% | May 29, 2026 |
| Robert McQuade | Director | – | – | May 29, 2026 |
| Justin D. Gover | Director | – | – | May 29, 2026 |
| Annalisa Jenkins | Director | 19,480 | 0.01% | Jun 13, 2025 |
| Linda McGoldrick | Director | – | – | Jun 13, 2025 |
| Thomas Lonngren | Director | 89,049 | 0.06% | Jun 13, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kabir Nath Chief Executive Officer, Director | Aug 3, 2026 | Tax withholding | −5,962 | $11.25 | $67.07K | 361,028 |
| Teri Loxam Chief Financial Officer | Mar 26, 2026 | Award | +75,000 | – | – | 152,002 |
| Kabir Nath Chief Executive Officer, Director | Mar 26, 2026 | Award | +175,000 | – | – | 366,990 |
| Kabir Nath Chief Executive Officer, Director | Mar 11, 2026 | Tax withholding | −13,131 | $6.89 | $90.47K | 191,990 |
| Teri Loxam Chief Financial Officer | Mar 11, 2026 | Tax withholding | −1,781 | $6.89 | $12.27K | 77,002 |
| Teri Loxam Chief Financial Officer | Mar 2, 2026 | Tax withholding | −4,467 | $7.02 | $31.36K | 78,783 |
| Kabir Nath Chief Executive Officer, Director | Feb 2, 2026 | Tax withholding | −16,181 | $6.61 | $106.96K | 205,121 |
| Kabir Nath Chief Executive Officer, Director | Aug 1, 2025 | Tax withholding | −6,366 | $4.34 | $27.63K | 221,302 |
| Kabir Nath Chief Executive Officer, Director | Mar 11, 2025 | Award | +92,000 | – | – | 227,668 |
| Teri Loxam Chief Financial Officer | Mar 11, 2025 | Award | +25,000 | – | – | 83,250 |
| Teri Loxam Chief Financial Officer | Mar 3, 2025 | Tax withholding | −4,468 | $3.67 | $16.40K | 58,250 |
| Kabir Nath Chief Executive Officer, Director | Feb 3, 2025 | Tax withholding | −15,516 | $4.31 | $66.87K | 135,668 |
| Ekaterina Malievskaia 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,155,122 |
| Ekaterina Malievskaia 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,152,848 |
| George Jay Goldsmith 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,152,848 |
| George Jay Goldsmith 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,155,122 |
| Life Sciences AG ATAI 10% owner | Sep 26, 2024 | Sale | −2,660,000 | $6.05 | $16.09M | 6,905,774 |
| Kabir Nath Chief Executive Officer, Director | Aug 1, 2024 | Tax withholding | −7,064 | $6.88 | $48.60K | 151,184 |
| Annalisa Jenkins Director | Aug 1, 2024 | Tax withholding | −161 | $6.88 | $1.11K | 19,480 |
| Ekaterina Malievskaia 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,931,687 |
| Ekaterina Malievskaia 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,929,413 |
| George Jay Goldsmith 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,929,413 |
| George Jay Goldsmith 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,931,687 |
| Ekaterina Malievskaia 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,703 | $7.89 | $52.89K | 3,940,587 |
| Ekaterina Malievskaia 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,704 | $7.89 | $52.89K | 3,938,313 |
| George Jay Goldsmith 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,704 | $7.89 | $52.89K | 3,938,313 |
| George Jay Goldsmith 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,703 | $7.89 | $52.89K | 3,940,587 |
| George Jay Goldsmith 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,762 | $8.82 | $165.48K | 3,947,290 |
| George Jay Goldsmith 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,761 | $8.82 | $165.47K | 3,945,017 |
| Ekaterina Malievskaia 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,762 | $8.82 | $165.48K | 3,947,290 |
| Ekaterina Malievskaia 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,761 | $8.82 | $165.47K | 3,945,017 |
| George Jay Goldsmith 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,621 | $8.29 | $79.76K | 3,966,052 |
| George Jay Goldsmith 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,622 | $8.29 | $79.77K | 3,963,778 |
| Ekaterina Malievskaia 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,622 | $8.29 | $79.77K | 3,963,778 |
| Ekaterina Malievskaia 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,621 | $8.29 | $79.76K | 3,966,052 |
| Annalisa Jenkins Director | May 1, 2024 | Tax withholding | −211 | $8.48 | $1.79K | 19,641 |
| George Jay Goldsmith 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,975,673 |
| George Jay Goldsmith 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,973,400 |
| Ekaterina Malievskaia 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,975,673 |
| Ekaterina Malievskaia 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,973,400 |
| George Jay Goldsmith 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,880 | $8.53 | $203.70K | 3,984,250 |
| George Jay Goldsmith 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,881 | $8.53 | $203.70K | 3,986,523 |
| Ekaterina Malievskaia 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,881 | $8.53 | $203.70K | 3,986,523 |
| Ekaterina Malievskaia 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,880 | $8.53 | $203.70K | 3,984,250 |
| George Jay Goldsmith 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,010,404 |
| George Jay Goldsmith 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,008,130 |
| Ekaterina Malievskaia 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,010,404 |
| Ekaterina Malievskaia 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,008,130 |
| George Jay Goldsmith 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,036,154 |
| George Jay Goldsmith 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,033,880 |
| Ekaterina Malievskaia 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,036,154 |
| Ekaterina Malievskaia 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,033,880 |
| George Jay Goldsmith Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,061,904 |
| George Jay Goldsmith Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,059,630 |
| Ekaterina Malievskaia Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,059,630 |
| Ekaterina Malievskaia Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,061,904 |
| George Jay Goldsmith Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,079,107 |
| George Jay Goldsmith Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,076,833 |
| Ekaterina Malievskaia Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,076,833 |
| Ekaterina Malievskaia Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,079,107 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of COMPASS Pathways's stock actually held short. Settlement fails (shares not delivered on time) peaked at 47,257 shares on Oct 7, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Annalisa Jenkins Former Director | Aug 10, 2026 | 26,000 | $345.80K | Aug 10, 2026 | Stock Option Exercise |
| Annalisa Jenkins Former Director | Aug 7, 2026 | 83,771 | $1.15M | Aug 7, 2026 | Stock Option Exercise |
| George Jay Goldsmith Other: CEO & Co-founder | Mar 13, 2024 | 432,291 | $4.61M | Mar 13, 2024 | Founder's Shares |
| Ekaterina Malievskaia Other: CIO & Co-founder | Mar 13, 2024 | 432,290 | $4.61M | Mar 13, 2024 | Founder's Shares |
| George Jay Goldsmith Other: CEO & Co-founder | Dec 13, 2023 | 309,000 | $2.22M | Dec 13, 2023 | Founder's Shares |
| Ekaterina Malievskaia Other: CIO & Co-founder | Dec 13, 2023 | 309,000 | $2.22M | Dec 13, 2023 | Founder's Shares |
Congress trades
1 trade in COMPASS Pathways reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Shri Thanedar MI13 | Sold | Jan 23, 2023 | $1K–15K | Feb 9, 2023 |
See a number that looks wrong?